American Green Inc. and Greenhouse Solutions Inc. announced a joint venture to formulate, market and distribute two proprietary topical CBD (cannabidiol) products. Utilizing Greenhouse Solutions' science team, the company will provide American Green with two base proprietary, proven topical pain formulations, one for humans and one for the equine market.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0004 USD | -20.00% | 0.00% | -42.86% |
2023 | American Green, Inc. Reports Preliminary Revenue Results for the Second Quarter Ending Dec. 2022 | CI |
2023 | American Green, Inc. Provides Revenue Guidance for the Fiscal Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-42.86% | 1.71M | |
-41.82% | 9.29B | |
-21.93% | 6.82B | |
-2.08% | 6.45B | |
+92.40% | 5.26B | |
-2.77% | 4.62B | |
+5.79% | 4.56B | |
-31.67% | 3.81B | |
+4.94% | 3.06B | |
-20.90% | 2.55B |
- Stock Market
- Equities
- ERBB Stock
- News American Green, Inc.
- American Green, Inc. and Greenhouse Solutions Inc. Announces Joint Venture to Formulate, Market and Distribute Two Proprietary Topical CBD(Cannabidiol) Products